Relation between vitamin D deficiency and Pseudomonas aeruginosa colonization in patients with bronchiectasis

Yu-Hua Wen1, Ruo-Xuan Dai1, Heng Yang1

  • 1Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China.

BMC Pulmonary Medicine
|February 14, 2025
PubMed
Abstract

Insights

Vitamin D deficiency is common in bronchiectasis patients and linked to increased Pseudomonas aeruginosa colonization. Vitamin D may offer protection by reducing bacterial survival and inflammation.

Area of Science:

  • Pulmonary Medicine
  • Microbiology
  • Immunology

Background:

  • The link between vitamin D deficiency and Pseudomonas aeruginosa colonization in bronchiectasis remains unclear.
  • Bronchiectasis patients often experience chronic bacterial infections, with P. aeruginosa being a common pathogen.

Purpose of the Study:

  • To investigate the association between vitamin D levels and P. aeruginosa colonization in bronchiectasis.
  • To explore the in vitro effects of vitamin D on P. aeruginosa infection and host immune response.

Main Methods:

  • Serum 25-hydroxyvitamin D levels and clinical data were collected from 195 bronchiectasis patients.
  • Correlation and logistic regression analyses were used to assess the relationship between vitamin D and P. aeruginosa colonization.
  • In vitro studies examined the impact of 1,25-dihydroxyvitamin D on P. aeruginosa-infected macrophages.

Main Results:

  • 83.1% of patients had vitamin D deficiency, which correlated with higher P. aeruginosa colonization rates.
  • Vitamin D deficiency and female gender were risk factors for P. aeruginosa colonization.
  • Vitamin D inhibited bacterial phagocytosis and reduced IL-1β secretion in vitro.

Conclusions:

  • Vitamin D deficiency is a significant risk factor for P. aeruginosa colonization in bronchiectasis.
  • Vitamin D exhibits protective effects against P. aeruginosa infection and associated inflammation.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
146
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
218
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
204
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
201
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K